Technical Analysis for VIVO - Meridian Bioscience Inc.

Grade Last Price % Change Price Change
grade D 10.03 0.40% 0.04
VIVO closed up 0.4 percent on Friday, October 18, 2019, on approximately normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Earnings due: Nov 7

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Up Up
See historical VIVO trend table...

Date Alert Name Type % Chg
MACD Bullish Centerline Cross Bullish 0.00%
NR7 Range Contraction 0.00%
NR7-2 Range Contraction 0.00%
Multiple of Ten Bullish Other 0.00%
Overbought Stochastic Strength 0.00%
Up 3 Days in a Row Strength 0.00%
Up 4 Days in a Row Strength 0.00%
Up 5 Days in a Row Strength 0.00%
NR7 Range Contraction 0.40%
NR7-2 Range Contraction 0.40%

Older signals for VIVO ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Meridian Bioscience, Inc., a life science company, develops, manufactures, sells, and distributes clinical diagnostic test kits primarily for gastrointestinal, viral, respiratory, and parasitic infectious diseases. The company's diagnostic products principally include C. difficile for the detection of gastrointestinal diseases, such as antibiotic-associated diarrhea; Rotavirus and Adenovirus products for pediatric diarrhea detection; H. pylori for the detection of stomach ulcers; EHEC test for the detection of Enterohemorrhagic E. coli infection and Campy for the detection of Campylobacter jejuni; and Group A Strep and Group B Strep tests for the detection of streptococcus bacterial infections. Its diagnostic products are also used in the detection of viral diseases, such as mononucleosis, herpes simplex, chicken pox, and shingles; organ transplant infections; parasitic diseases, including giardiasis, cryptosporidiosis, and lyme; and respiratory diseases, such as pneumonia, valley fever, influenza, and respiratory syncytial virus. The company also offers transport media that store and preserve specimen samples from patient collection to laboratory testing; and bulk antigens, antibodies, PCR/qPCR reagents, nucleotides, competent cells, and bioresearch reagents used by researchers and other diagnostic companies. In addition, it engages in the contract development and manufacture of proteins and other biologicals under cGMP conditions for use by biopharmaceutical and biotechnology companies engaged in research for new drugs and vaccines; and sale and distribution of diagnostic test kits manufactured by third-party vendors. The company markets its products through direct sales force and independent distributors primarily to hospitals, reference laboratories, and research customers in the United States, Asia, Canada, South America, Australia, Europe, Africa, and the Middle East. Meridian Bioscience, Inc. was founded in 1976 and is headquartered in Cincinnati, Ohio.
Medicine Biotechnology Antibodies Influenza Diagnostic Products Diarrhea Gastrointestinal Diseases Respiratory Diseases Pneumonia Viral Diseases Herpes Simplex Zoonoses Human Orthopneumovirus Organ Transplant Shingles Waterborne Diseases
Is VIVO a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 19.84
52 Week Low 8.82
Average Volume 252,063
200-Day Moving Average 12.7343
50-Day Moving Average 9.6679
20-Day Moving Average 9.5343
10-Day Moving Average 9.47
Average True Range 0.3313
ADX 17.65
+DI 27.7018
-DI 15.8074
Chandelier Exit (Long, 3 ATRs ) 9.1961
Chandelier Exit (Short, 3 ATRs ) 9.8139
Upper Bollinger Band 10.2874
Lower Bollinger Band 8.7812
Percent B (%b) 0.83
BandWidth 15.797699
MACD Line 0.0054
MACD Signal Line -0.1071
MACD Histogram 0.1125
Fundamentals Value
Market Cap 423.3 Million
Num Shares 42.2 Million
EPS 0.50
Price-to-Earnings (P/E) Ratio 20.06
Price-to-Sales 3.13
Price-to-Book 3.70
PEG Ratio 1.29
Dividend 0.50
Dividend Yield 4.99%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 10.30
Resistance 3 (R3) 10.30 10.20 10.26
Resistance 2 (R2) 10.20 10.13 10.21 10.24
Resistance 1 (R1) 10.12 10.09 10.16 10.12 10.22
Pivot Point 10.02 10.02 10.05 10.03 10.02
Support 1 (S1) 9.94 9.95 9.98 9.94 9.84
Support 2 (S2) 9.84 9.91 9.85 9.82
Support 3 (S3) 9.76 9.84 9.81
Support 4 (S4) 9.76